These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group. Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053 [Abstract] [Full Text] [Related]
30. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Wakai K, Nakai S, Kikuchi K, Iseki K, Miwa N, Masakane I, Wada A, Shinzato T, Nagura Y, Akiba T. Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379 [Abstract] [Full Text] [Related]
31. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain]. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M, Sanz P, Barril G, Selgas R, Salgueira M, Palma A, de la Torre M, Ferreras I. Nefrologia; 2002 Aug; 22(1):49-59. PubMed ID: 11987685 [Abstract] [Full Text] [Related]
34. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy. Eachempati SR, Wang JC, Hydo LJ, Shou J, Barie PS. J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940 [Abstract] [Full Text] [Related]
35. Is there any survival advantage of obesity in Southern European haemodialysis patients? Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D. Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686 [Abstract] [Full Text] [Related]